<DOC>
	<DOCNO>NCT02334969</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Naoxintong Capsule secondary prevention ischemic stroke multi-center , randomize , double-blind，placebo-controlled trial design project .</brief_summary>
	<brief_title>Curative Efficacy Secondary Prevention Patients With Ischemic Stroke Through Syndrome Differentiation TCM</brief_title>
	<detailed_description>The research employ random , double-blind , multicenter , placebo parallel control design observe clinical effect Naoxintong capsule treatment ischemic stroke blood stasis syndrome secondary prevention，which fund Science Technology Commission Shanghai Municipality.The therapeutic drug research Naoxintong capsule market treatment prevention stroke , applicable stroke patient cause qi deficiency , blood stasis venation stasis.The research carry 24 hospitals.It total number 2200 volunteers，who meet inclusion criterion exclusion criterion agree participate research.Volunteers randomly assign experimental group control group . The trial drug experimental group Naoxintong capsule , control group kind placebo capsule.Volunteers regularly follow experimental period 2 year . It evaluate clinical efficacy Naoxintong capsule secondary prevention stroke recurrence mortality .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Adult volunteer age ≤ 90 year old , ≥18 year old； Conforming diagnostic criterion cerebral infarction 2010 version Chinese Guidelines Treatment Acute Ischemic Stroke； Conforming diagnostic criterion stasis type TCM ischemic stroke； The onset acute cerebral infarction ≥ 10 days； Consciousness awake； Volunteers agree accept program sign inform consent . Excluding patient yin deficiency type ischemic stroke.The diagnostic criterion Yin deficiency type ischemic stroke sudden onset disease；being sign symptom neurological deficit；CT MRI examination show intracranial ischemic lesions；Scarlet tongue； The volunteer severe heart disease , cardiac insufficiency , hepatosis , renal insufficiency , respiratory failure , malignant tumour , alimentary tract hemorrhage , etc . may fail complete twoyear followup； Psychiatric patients； Pregnants lactate women； Volunteers clinical trials； Volunteers suitable clinical trial accord researcher reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>ischemic stroke；Naoxintong Capsule</keyword>
</DOC>